DoseCompass / Medications / Qelbree
Qelbree
viloxazine ER · Non-stimulant
The newest non-stimulant (2021): extended-release viloxazine, a norepinephrine modulator. An option when stimulants and atomoxetine don’t fit; brand-only with a copay card.
*Approximate U.S. cash price for a 30-day supply with a free discount card, mid-2026. Compare current prices on GoodRx.
Available strengths
100 mg · 150 mg · 200 mg
Coverage
24-hour coverage once established (2–6 weeks to full effect). Unlike stimulants, coverage doesn’t switch on and off the same day — the effect builds with consistent daily dosing.
Why there are no dose equivalents
Qelbree works through a different mechanism than stimulants, so no conversion ratio exists between it and Adderall, Vyvanse, or Ritalin. Prescribers start at a standard dose and titrate by response — independent of any stimulant dose you were taking. The converter will tell you the same thing.
Common questions
What strengths does Qelbree come in?
Qelbree (viloxazine ER) is available in: 100, 150, 200 mg.
How long does Qelbree last?
24-hour coverage once established (2–6 weeks to full effect).
Is there a generic Qelbree?
No — it is currently brand-only, typically $300–400/month cash. The manufacturer copay card can substantially reduce the price for commercially insured patients.
Is Qelbree a stimulant?
No. Qelbree (viloxazine ER) is a non-stimulant that works through a different mechanism, so there is no dose equivalence with Adderall, Vyvanse, or Ritalin — it is titrated on its own schedule and is not a controlled substance in the way stimulants are.